Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

KRX/003000 stock hub

KRX/003000 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRX/003000is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

590B

Korea Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

KRX/003000

In the news

Latest news · KRX/003000

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.8P50 17.1P75 31.9

Trailing P/E39.3

P25 12P50 23.1P75 39.5

ROE4.3

P25 -17.1P50 0.7P75 8.5

ROIC6.9

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRX/003000 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

229

Groups with data

Currency

KRW

Showing 229 of 229 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	615
Enterprise value	KRW 454.5B
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KR7003000007
Last refreshed	2026-05-10
Market cap	KRW 590B
Price	KRW 5,980
Price currency	KRW
Rev Per Employee	326,364,526.33x
Sector	Healthcare
Sic	2834
Symbol	krx/003000
Website	https://www.bukwang.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.13%
EV Earnings	36.19x
EV/EBIT	32.05x
EV/EBITDA	23.1x
EV/FCF	31.99x
EV/Sales	2.26x
FCF yield	2.41%
P/B ratio	1.73x
P/E ratio	39.34x
P/S ratio	2.94x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	7.06%
EBITDA Margin	9.79%
FCF margin	7.08%
Gross margin	45.6%
Gross Profit	KRW 91.5B
Gross Profit Growth	23.58%
Gross Profit Growth Q	53.18%
Gross Profit Growth3 Y	4.96%
Gross Profit Growth5 Y	5.11%
Net Income	KRW 12.6B
Net Income Growth Q	152.76%
Net Income Growth Quarters	7%
Net Income Growth Years	2%
Pretax Margin	3.18%
Profit Margin	6.26%
Profit Per Employee	KRW 20.4M
Profitable Years	1
ROA	2.08
Roa5y	-0.49
ROCE	3.95
ROE	4.25
Roe5y	-2.67
ROIC	6.93
Roic5y	-3.12

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-6.9%
Cagr15y	3.78%
Cagr1y	66.84%
Cagr20y	2.17%
Cagr3y	-6.5%
Cagr5y	-20.56%
Div CAGR10	-9.87%
Div CAGR3	7.72%
Div CAGR5	4.56%
EPS Growth Q	64.26
EPS Growth Quarters	1
EPS Growth Years	2
FCF Growth	-56.19%
FCF Growth Q	-26.25%
FCF Growth3 Y	5.31%
OCF Growth	-37.54%
OCF Growth Q	-9.53%
OCF Growth10 Y	7.62%
OCF Growth3 Y	9.25%
OCF Growth5 Y	97.01%
Revenue Growth	25.38x
Revenue Growth Q	35.37x
Revenue Growth Years	2x
Revenue Growth3 Y	1.68x
Revenue Growth5 Y	3.42x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.47
Assets	KRW 476.3B
Cash	KRW 216.2B
Current Assets	KRW 303.2B
Current Liabilities	KRW 117.8B
Debt	KRW 80.3B
Debt EBITDA	KRW 4.09
Debt Equity	KRW 0.24
Debt FCF	KRW 5.66
Equity	KRW 340.9B
Interest Coverage	3.64
Liabilities	KRW 135.4B
Long Term Assets	KRW 173.1B
Long Term Liabilities	KRW 17.5B
Net Cash	KRW 135.9B
Net Cash By Market Cap	KRW 23.03
Net Cash Growth	168.16%
Net Debt EBITDA	KRW -6.91
Net Debt Equity	KRW -0.4
Net Debt FCF	KRW -9.56
Tangible Book Value	KRW 335.5B
Tangible Book Value Per Share	KRW 3,260
WACC	5.32

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.57
Inventory Turnover	2.33
Net Working Capital	KRW 49B
Quick ratio	2.09
Working Capital	KRW 185.4B
Working Capital Turnover	KRW 1.13

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-21.98%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	KRW 150
Dividend Years	1
Dividend Yield	2.51%
Ex Div Date	2025-12-29
Last Dividend	KRW 75
Payout Ratio	39.28%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-51.1%
1Y total return	66.78%
200-day SMA	4,523.8
3Y total return	-18.27%
50-day SMA	6,841.1
50-day SMA vs 200-day SMA	50over200
5Y total return	-68.36%
All Time High	42,318.2
All Time High Change	-85.87%
All Time High Date	2020-07-21
All Time Low	219.2
All Time Low Change	2,628.1%
All Time Low Date	1994-01-27
ATR	546.5
Beta	0.23
Beta1y	-0.25
Beta2y	0.27
Ch YTD	57.99
High	6,150
High52	9,890
High52 Date	2026-03-27
High52ch	-39.53%
Low	5,850
Low52	3,200
Low52 Date	2025-08-04
Low52ch	86.88%
Ma50ch	-12.59%
Price vs 200-day SMA	32.19%
RSI	36.26
RSI Monthly	54.13
RSI Weekly	52.14
Sharpe ratio	0.99x
Sortino ratio	1.91
Total Return	-19.48%
Tr YTD	57.99
Tr15y	74.44%
Tr1m	-20.58%
Tr1w	-4.93%
Tr3m	48.76%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW 14.2B
Operating Income Growth	775.6
Operating Income Growth Q	317.8
Operating Income Growth5 Y	28.59
Operating margin	7.06

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	67,739,351%
Net Borrowing	-459,422,830
Shares Insiders	14.01%
Shares Institutions	3.68%
Shares Out	98,664,671
Shares Qo Q	-26.04%
Shares Yo Y	21.98%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW 14.2B
Average Volume	1,949,942x
Bv Per Share	3,309.6
CAPEX	KRW -7.3B
Ch10y	-57.75
Ch15y	32.29
Ch1m	-20.58
Ch1w	-4.93
Ch1y	52.36
Ch20y	4
Ch3m	48.76
Ch3y	-25.34
Ch5y	-71.32
Ch6m	60.97
Change	-0.33%
Change From Open	-0.99
Close	6,000
Days Gap	0.67
Depreciation Amortization	5,488,676,900
Dollar Volume	6,336,437,900
Earnings Date	2026-04-21
EBIT	KRW 14.2B
EBITDA	KRW 19.7B
EPS	KRW 152
F Score	5
FCF	KRW 14.2B
FCF EV Yield	3.13x
FCF Per Share	KRW 144
Financing CF	79,783,729,040
Fiscal Year End	December
Founded	1,960
Graham Number	3364.34134
Graham Upside	-43.74
Income Tax	KRW -6B
Investing CF	-95,681,715,630
Is Primary Listing	1
Last Earnings Date	2026-02-08
Last Report Date	2025-12-31
Last Split Date	2020-12-29
Last Split Type	Forward
Ma150	4,879.8
Ma150ch	22.55%
Ma20	7,214
Ma20ch	-17.11%
Net CF	6,117,044,710
Open	6,040
P FCF Ratio	41.53
P OCF Ratio	27.49
Payment Date	2026-04-23
Position In Range	43.33
Ppne	144,984,754,800
Price Date	2026-05-08
Price EBITDA	KRW 30.02
Ptbv Ratio	1.76
Relative Volume	0.53x
Revenue	200,714,183,690x
SBC By Revenue	0.01x
Share Based Comp	13,204,950
Tax By Revenue	-3.01x
Tr20y	53.68%
Tr6m	60.97%
Volume	1,059,605
Z Score	2.91

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

KRX/003000 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.5%

$150 annual per share

Payout ratio

+39.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+4.6%

1 consecutive years of growth

Total shareholder yield

-19.5%

Next ex-dividend date: 2025-12-29

Performance

KRX/003000 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KRX/003000?

Insider, institutional, and short-interest positioning.

Institutional ownership

+3.7%

Share of float held by funds and institutions

Insider ownership

+14.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+22.0%

Negative means the company is buying back shares.

Technical

KRX/003000 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

36.3

Neutral momentum band

Price vs 200-day MA

+32.2%

50/200-day relationship not available

Beta (5Y)

0.23

Less volatile than the market

Sharpe ratio

0.99

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRX/003000

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/003000 stock rating?

krx/003000 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/003000 analysis?

The full report lives at /stocks/krx/003000/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/003000?

The latest report frames krx/003000 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/003000 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.